For the study, researchers tracked 1,070 kids aged 12 to 18 who were overweight or obese and also had a diagnosis of asthma.

Two replicate phase 3 trials of GB-0895, an anti-thymic stromal lymphopoietin antibody, are enrolling adults and adolescents ...

More must be done to ensure that asthma patients get access to cutting-edge treatments, experts have said, after research ...

Air pollution is no longer just an environmental headline, it’s slowly becoming a daily health reality for children, ...

An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available ...

Kamal Kumar Singhal, a 44-year-old resident of Uttamnagar, Delhi, has been living with asthma since 2018. Initially, he ...

SAVING’ jab for severe asthma that could prevent deadly attacks with just two doses a year could be available to patients in ...

An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available ...

Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...

Regarding who can use these inhalers, NHS guidelines state: "Most adults can use beclometasone inhalers for asthma or COPD.

This year’s top asthma and respiratory disorder story focused on the pushback from multiple advocacy groups following ...

What is Exdensur? A new FDA-approved asthma biologic from GSK that only needs two doses a year for severe eosinophilic asthma ...